Literature DB >> 6289729

Stimulation of human and canine neutrophil metabolism by amphotericin B.

S R Supapidhayakul, L R Kizlaitis, B R Andersen.   

Abstract

The effect of an antifungal agent, amphotericin B, on human and canine neutrophil metabolism was studied. Commercial preparations of amphotericin B in concentrations ranging from 5 to 100 micrograms/ml stimulated neutrophil chemiluminescence in the presence of 10(-8) M luminol. This response was blocked by 2-deoxyglucose, a metabolic inhibitor, and by the absence of extracellular calcium ions. Neither pure amphotericin B nor the solubilizing agent present in the commercial preparation, alone or in combination, stimulated neutrophil chemiluminescence. Commercial amphotericin B caused an increase in oxygen uptake by neutrophils but no detectable superoxide anion production. Neutrophils were injured by commercial amphotericin B, as shown by an increase in trypan blue dye uptake but not cell lysis. Binding of amphotericin B to neutrophil membrane sterol with a subsequent alteration in membrane configuration is the most likely cause of metabolic stimulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6289729      PMCID: PMC181410          DOI: 10.1128/AAC.19.2.284

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Neutrophil toxicity of amphotericin B.

Authors:  C J Chunn; P R Starr; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.

Authors:  B Björkstén; C Ray; P G Quie
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

3.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Use of a unique chemiluminescence spectrometer in a study of factors influencing granulocyte light emission.

Authors:  B R Andersen; A M Brendzel
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  The action of polyene antibiotics on lipid bilayer membranes in the presence of several cations and anions.

Authors:  H van Zutphen; R A Demel; A W Norman; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1971-08-13

7.  Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells.

Authors:  J Kotler-Brajtburg; H D Price; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

8.  Composition and properties of a cell-membrane fraction from the polymorphonuclear leucocyte.

Authors:  A M Woodin; A A Wieneke
Journal:  Biochem J       Date:  1966-05       Impact factor: 3.857

9.  Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes.

Authors:  B de Kruijff; R A Demel
Journal:  Biochim Biophys Acta       Date:  1974-02-26

10.  The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B.

Authors:  A Cass; A Finkelstein; V Krespi
Journal:  J Gen Physiol       Date:  1970-07       Impact factor: 4.086

View more
  8 in total

1.  Enhancement of macrophage superoxide anion production by amphotericin B.

Authors:  E Wilson; L Thorson; D P Speert
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.

Authors:  G K Abruzzo; D M Giltinan; T P Capizzi; R A Fromtling
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Effects of antifungal agents on the function of human neutrophils in vitro.

Authors:  E Roilides; T J Walsh; M Rubin; D Venzon; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

5.  Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.

Authors:  Emmanuel Roilides; Caron A Lyman; Joanna Filioti; Onome Akpogheneta; Tin Sein; Cristina Gil Lamaignere; Ruta Petraitiene; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen.

Authors:  J M Boggs; N H Chang; A Goundalkar
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

8.  Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.